ASHP—Preventing and Treating Recurrent Cdiff Infection in High-Risk Populations (Advanced Practice)

February 1, 2021 - May 31, 2022

Location

On-Demand

This class is available on the ASHP website until May 31, 2022.
Date

February 1, 2021
May 31, 2022

Class Description

This free, 1.5-hour interprofessional online continuing education program is available free on the American Society of Health-System Pharmacists website through May 31, 2022. The target audience is pharmacists, physician assistants, or nurse practitioners who care for patients at risk for recurrent Clostridioides difficile Infection.

Objectives

This 1.5-hour interprofessional educational activity uses a point-counterpoint approach to decision making for managing special patient populations at high-risk for poor outcomes also taking into account cost-benefit considerations. Learning objectives:
  • Distinguish how current Clostridioides difficile infection (CDI) therapies prevent CDI recurrence.
  • Identify patients that would benefit from fidaxomicin or vancomycin with another anti-CDI recurrence strategy.
  • Identify patient populations in which an anti-CDI recurrence strategy would be most cost effective in practice.
  • Develop an interprofessional treatment plan for recurrent CDI for special populations.

Registration

Registration for the online program is available on the ASHP website: http://symposia.ashp.org/lms/content/21-highriskcdiff/

To receive CE credit, complete the steps below within 60 days of completing the activity. View entire presentation and answer all polling questions. Click "Complete Activity" on the last slide to link to complete the assessment and evaluation. Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account.